Application of antimicrobial stewardship to optimise management of community acquired pneumonia

被引:31
作者
Bosso, J. A. [1 ,2 ]
Drew, R. H. [3 ,4 ]
机构
[1] Med Univ S Carolina, Coll Med, Dept Clin Pharm & Outcome Sci, S Carolina Coll Pharm, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Coll Med, Div Infect Dis, Charleston, SC 29425 USA
[3] Campbell Univ, Coll Pharm & Hlth Sci, Buies Creek, NC 27506 USA
[4] Duke Univ, Sch Med, Durham, NC USA
关键词
INFECTIOUS-DISEASES-SOCIETY; HEALTH-CARE EPIDEMIOLOGY; GRAM-NEGATIVE BACILLI; ANTIBIOTIC-RESISTANCE; PATIENT OUTCOMES; CRITICAL PATHWAY; UNITED-STATES; EARLY SWITCH; GUIDELINES; AMERICA;
D O I
10.1111/j.1742-1241.2011.02704.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to review the application of antimicrobial stewardship principles to the management of community-acquired pneumonia (CAP). Data from 14 published clinical studies, meta-analyses and practice guidelines regarding the application of antimicrobial stewardship strategies to the management of CAP were identified and analysed. In the context of CAP, application of stewardship strategies (alone or in combination) has been shown to increase physician awareness of guidelines, improve appropriate antimicrobial use and reduce unnecessary antimicrobial prescribing. In addition, application has had a profound favourable impact on patient outcomes, including decreased 30-day mortality and in-hospital mortality rates, reduced length of hospital stay, reduced treatment failure rates and reduced healthcare costs. Antimicrobial stewardship programmes have been demonstrated to successfully increase the level of appropriate antibiotic prescribing, reduce pathogen resistance and improve clinical outcomes in the management of CAP within hospitals. Studies have also shown that adherence to evidence-based guidelines, even at the level of the individual clinician, can have a profound and positive impact on patient outcomes and healthcare costs. Adherence to evidence-based guidelines can have a profound and positive impact on patient outcomes and healthcare costs.
引用
收藏
页码:775 / 783
页数:9
相关论文
共 38 条
[1]   Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006 [J].
Adam, Heather J. ;
Hoban, Daryl J. ;
Gin, Alfred S. ;
Zhanel, George G. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (01) :82-85
[2]  
[Anonymous], J RESP DIS
[3]   Early Switch to Oral Treatment in Patients with Moderate to Severe Community-Acquired Pneumonia A Meta-Analysis [J].
Athanassa, Zoe ;
Makris, Gregory ;
Dimopoulos, George ;
Falagas, Matthew E. .
DRUGS, 2008, 68 (17) :2469-2481
[4]  
Benninger Michael, 2008, J Fam Pract, V57, pS5
[5]   Can CAP guideline adherence improve patient outcome in internal medicine departments? [J].
Blasi, F. ;
Iori, I. ;
Bulfoni, A. ;
Corrao, S. ;
Costantino, S. ;
Legnani, D. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (04) :902-910
[6]   Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia:: A controlled before-and-after design study [J].
Capelastegui, A ;
España, PP ;
Quintana, JM ;
Gorordo, I ;
Ortega, M ;
Idoiaga, I ;
Bilbao, A .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) :955-963
[7]   Treatment costs of community-acquired pneumonia in an employed population [J].
Colice, GL ;
Morley, MA ;
Asche, C ;
Birnbaum, HG .
CHEST, 2004, 125 (06) :2140-2145
[8]   The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs [J].
Cosgrove, SE .
CLINICAL INFECTIOUS DISEASES, 2006, 42 :S82-S89
[9]   The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes:: Mortality, length of stay, and hospital charges [J].
Cosgrove, SE ;
Qi, YL ;
Kaye, KS ;
Harbarth, S ;
Karchmer, AW ;
Carmeli, Y .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (02) :166-174
[10]   Prospective evaluation of the treatment and outcome of community-acquired pneumonia according to the Pneumonia Severity Index in VHA hospitals [J].
Davydov, L ;
Ebert, SC ;
Restino, M ;
Gardner, M ;
Bedenkop, G ;
Uchida, KM ;
Bertino, JS .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (04) :267-275